LILRB2 and myeloid sarcoma: Using quantitative RT-PCR, leukocyte immunoglobulin-like receptor B2 (LILRB2), also called immunoglobulin-like transcript 4 (ILT4), has been reported to be upregulated in active lesions in the MS brain compared to the control brain [42].